Poster

Platforming mAbPurification Process Using Matched Component Chromatographic Clarification Approach

Source: 3M Purification

By Alexei Voloshin, Derek Pendlebury, and Gregory Jellum

Monoclonal antibodies comprise the most dynamic segment of bio-therapeutics market and are predicted to top $100 Billion USD in sales in 2015. To sustain this rapid market growth into the future biopharmaceutical industry requires new generations of mAb production processes from discovery to commercial manufacturing.

access the Poster!

Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Pharmaceutical Online

Please tell us more about you so that we can customize our newsletters to your specific interests: